|Property||Resources - Mining|
|Resources - Oil & Gas||Technology|
|UK Commercial Property Trust||F&C Managed Portfolio Trust|
|Custodian REIT||Target Healthcare REIT|
|Blancco Technology Group||Collplant Holdings|
Valiant Petroleum is an independent oil and gas exploration, development and production company, focused on the UK segment of the North Sea.
Vatukoula Gold Mines is a producing gold miner with assets in Fiji, where the company is currently reconfiguring its underground operation to allow the expansion of production to the targeted rate of 100,000oz/year.
Velocys (formerly Oxford Catalysts) enables modular small scale gas to liquids plants to convert unconventional, stranded and associated or flared gas into valuable liquid fuel. These gas fields represent a 25mb/d opportunity.
Veris Gold Corp operates its Jerritt Canyon mine and processing plant in north Nevada, US. It currently extracts gold from three mines (Smith, SSX/Steer and Starvation Canyon).
Vernalis is a UK speciality pharma company with an FDA-approved, prescription-only cough cold treatment, Tuzistra XR; an FDA approved amoxicillin, Moxatag; and a late-stage US cough cold pipeline of four products.
Vertex Energy is an environmental services company that recycles industrial waste streams, and off-specification commercial chemical products. Its primary focus is recycling used motor oil (UMO) and other petroleum by-product streams.
Vertu is the fifth largest UK motor vehicle retailer. Established in 2006, it is expanding through the completion and subsequent development of a series of acquisitions, initially in volume cars, but now including the premium segment of the market.
Victoria Goldâ€™s flagship project, Eagle Gold, is located in the 100%-owned Dublin Gulch property in the Yukon Territory, Canada. Victoria Gold also intends to continue exploration of the Potato Hills Trend, with a view of further enhancing Eagleâ€™s already robust economics. The company is debt free.
Victrex manufactures and markets high performance PEEK polymers (monomer BDF). VPS markets to the transport, industrial and electronic sectors. Invibio markets to medical device makers.
VNI’s objective is to achieve medium- to long-term (four to six years) capital appreciation and provide an attractive level of income (from interest and dividends) through investing in a diversified portfolio of mainly Vietnamese infrastructure and infrastructure-related assets. In 2011 VNI shifted its strategic focus to ensure the fund was positioned to grow its assets and return value to shareholders.
VinaLand (VNL) is a closed-end, Cayman Islands-registered, exempted company. Launched in 2006, it has a diversified portfolio of Vietnamese property and property development projects. It is in a cash return period and will seek to realise assets in the existing portfolio and continue with the development of selected projects to maximise value.
Viralytics is a biopharmaceutical company developing Cavatak oncolytic virotherapy to target late-stage melanoma and other solid tumour types. It is trialling Cavatak as a monotherapy and in combination with checkpoint inhibitors.
Virtual Piggy provides an online payments and security platform that allows merchants to cater to the under-18 youth market.
Vivus is a Nasdaq-listed biotechnology company developing therapeutics for treating obesity and sexual health. It markets an erectile dysfunction treatment, and in 2007 licensed rights to EvaMist, a transdermal estradiol spray for menopause symptoms, to KV Pharmaceutical.
VMob Group is one of a new breed of mobile marketing enablers. Its software as a service (SaaS) product is designed to help global retailers drive more foot traffic through bricks and mortar stores.
VolitionRx is a Belgium-based diagnostics company focused on developing blood-based cancer diagnostics based on its proprietary NuQ technology. Its lead program is in colorectal cancer, which may enter the European market in 2016.
VASCO is a global internet security company with a leading position in strong authentication and e-signature solutions. The DIGIPASS family of hardware and software products is used by more than 10,000 companies.
Vectura is a UK speciality pharmaceutical company developing a range of inhaled therapies and technologies, principally for the treatment of respiratory diseases such as asthma and COPD.
Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells (CSCs). Its lead drug is VS-6063, a FAK inhibitor, currently in Phase II testing.
Verisante is a Canadian medical device company developing and commercialising its laser Raman spectroscopy technology for the detection of multiple cancer types. Key devices are Aura for skin, and Core for lung, colon and cervical cancers.
Vertex is a global biotech company that aims to discover, develop and commercialise innovative drugs for serious diseases. It has two approved drugs: Incivek for HCV and Kalydeco for CF. Other pipeline drugs include VX-222 and VX-135 (HCV), VX-809 and VX-661 (CF), VX-509 (inflammatory) and VX-787 (influenza).
Victoria Goldâ€™s flagship project, Eagle Gold, is located in the 100%-owned Dublin Gulch property in the Yukon Territory, Canada. Victoria Gold is looking to monetise its Santa Fe project in Nevada, US.
Victoria Oil & Gas is an E&P company with a focus on Cameroon. Its main asset is in Douala where it has developed a vertically integrated, utility-type approach to supply energy-hungry local businesses. It also owns an exploration block in Russia.
VietNam Holding (VNH) is an investment company established in 2006 to invest principally in the securities of former state-owned enterprises Vietnam and other companies where a significant portion of assets/operations are in Vietnam. The manager is VietNam Holding Asset Management (offices in Zurich and Ho Chi Minh City).
VOF aims to generate capital growth over the medium to long term from investment in Vietnam but it may also have exposure to Cambodia, Laos and Southern China. The investments encompass listed and unlisted companies, debt instruments, private equity and real estate. The principal sector focus is on financial services, property investment, hospitality management and retailing.
Vindon manufactures and provides controlled environment testing chambers and offsite storage of samples and laboratory research material, The core area is the pharmaceutical sector, with a number of major blue-chip clients, but the group is also expanding into areas like historical artefacts and cryogenic storage.
ViroPharma is a US speciality pharma company focused on the commercialisation and development of therapeutics for rare/orphan diseases. Its key marketed drug is Cinryze for hereditary angioedema. Buccolam for epileptic seizures and Plenadren for adrenal insufficiency are also sold in Europe. Key pipeline candidates in Phase II studies include: Cinryze SC, maribavir for cytomegalovirus and VP-20621 for C. difficile.
The fund aims to provide long-term capital growth by investing in a portfolio of companies whose operations at the time of initial investment are principally in greater China or investment vehicles used to acquire these.
Vivalis is a French stem cell company developing cell technologies for the manufacture of vaccines and antibodies. It also has an antibody discovery business. The combined entity will inherit Intercell?s portfolio of vaccines for the prevention and treatment of infectious diseases.
The successful completion of the Mosart acquisition combined with strong growth within the Broadcasting Graphics segment places Vizrt in an encouraging position for FY14. MAM is showing continued weakness, however, resulting in a $4.9m impairment of goodwill in Q413. Management has guided to low double-digit organic revenue growth consistent with consensus forecasts but excludes any contribution from Mosart, which could therefore provide upside.
Volex Group is a leading global provider of power products and interconnect cable assemblies. It supplies data and telecom equipment and healthcare and industrial products to large OEMs of consumer electrical and electronic devices.
Volt Resources Limited, formerly Mozambi Resources Limited, is an Australia-based graphite exploration company. The Company's principal activities include graphite exploration in Mozambique and Tanzania, and coal exploration in Queensland, Australia. It operates through segments, including Mineral Exploration- Mozambique and Mineral Exploration-Australia. Its graphite projects include Balama-Montepuez and Nachingwea. Its Balama-Montepuez project has licenses in Northern Mozambique near the regional center of Balama in Cabo Delgado province. The Nachingwea Project consists of over 18 tenements in South Eastern Tanzania within the Mozambique Mobile Belt. Its coal projects include Queensland; Tete West, which has tenement 3245L that is located around 12 kilometers west of the city of Tete and covers approximately 182 square kilometers, and Muturara, which has tenement 3246L that is located around 58 kilometers south east of the city of Tete and covers over 202 square kilometers.
Vp plc is a specialist rental business providing products and services to a diverse range of markets, including civil engineering, rail, oil and gas exploration, construction, outdoor events and industry, primarily within the UK (85%), but also overseas. Its businesses include UK Forks and materials handling; Groundforce - specialist groundworks; Hire Station - tool hire (B2B and B2C); Torrent Trackside - railway plant, staff; Airpac Bukom - oilfield services; and TPA -portable roadways.